

| Package | Price per Dose | Price | |
|---|---|---|---|
| 360 pills | £0.86 | £388.93 £311.14 Free shipping | |
| 180 pills | £0.94 | £211.76 £169.41 Free shipping | |
| 120 pills | £1.04 | £156.39 £125.12 | |
| 90 pills | £1.10 | £123.18 £98.54 | |
| 60 pills | £1.18 | £88.57 £70.86 | |
| 30 pills | £1.28 | £48.43 £38.75 | |
| 10 pills | £1.35 | £16.60 £13.28 | |
| 360 pills | £1.23 | £553.64 £442.92 Free shipping | |
| 240 pills | £1.27 | £382.01 £305.61 Free shipping | |
| 180 pills | £1.35 | £304.50 £243.60 Free shipping | |
| 120 pills | £1.48 | £222.83 £178.27 Free shipping | |
| 90 pills | £1.61 | £181.31 £145.05 | |
| 60 pills | £1.71 | £127.33 £101.86 | |
| 30 pills | £1.84 | £69.19 £55.35 | |
| 10 pills | £2.00 | £24.90 £19.92 | |
| 180 pills | £1.83 | £411.08 £328.86 Free shipping | |
| 120 pills | £1.88 | £282.35 £225.88 Free shipping | |
| 90 pills | £1.97 | £221.45 £177.16 Free shipping | |
| 60 pills | £2.10 | £157.78 £126.22 | |
| 30 pills | £2.30 | £85.80 £68.64 | |
| 10 pills | £2.60 | £33.21 £26.56 |
Disclaimer: This page provides general information about Amaryl (glimepiride). It is not a substitute for professional medical advice. Always consult a clinician or pharmacist for personal guidance.
In type 2 diabetes, the body often still produces insulin but does not respond to it as well as it should. This mismatch is a common reason blood sugar can rise despite a healthy diet and activity. Amaryl, or glimepiride, belongs to the sulfonylurea class of medicines. It works by stimulating insulin release from the pancreas, helping to lower blood glucose when meals and exercise alone do not achieve targets.
Amaryl is an oral antidiabetic medicine prescribed for adults with type 2 diabetes as part of a broader management plan that includes diet, exercise, and weight control. It is not intended for type 1 diabetes or diabetic ketoacidosis, and it should be used under medical supervision in the United Kingdom or where locally approved. Your healthcare professional will consider your overall health, other medicines you take, and your blood glucose patterns when deciding if Amaryl is appropriate.
Within the wider family of diabetes medicines, Amaryl sits among agents that increase insulin secretion. Other options include metformin, SGLT2 inhibitors, DPP-4 inhibitors, and insulin in some cases. Medicine choice depends on factors such as how much insulin your body still makes, how well different drugs lower your blood sugar, side‑effects, and how easy the regimen will be to fit into daily life.
Amaryl is typically used along with a healthy eating plan and physical activity. Your clinician may adjust your treatment over time, possibly adding other medicines if needed or switching to a different agent to balance efficacy with safety and tolerability. If you have questions about where Amaryl fits for you, discuss them with your doctor or pharmacist.
Amaryl is prescribed to improve glycemic control in adults with type 2 diabetes when diet, exercise, and other measures alone do not achieve target blood glucose. It may be used as a single therapy in some cases, or in combination with other diabetes medicines. Your clinician will tailor treatment to your blood sugar levels, body weight, and any other health conditions.
Choosing Amaryl over alternatives depends on several factors. If a patient has preserved beta cell function and a lower risk of hypoglycemia, a clinician might consider a different agent or a different sulfonylurea. In some patients, cost, tablet size, and dosing convenience influence the choice. If kidney function is reduced or if there are concerns about interactions with other medicines, the doctor may adjust the plan or select a different therapy.
Metformin is commonly used as first-line therapy in type 2 diabetes, with additional agents added if needed. Sulfonylureas like Amaryl are often considered when additional lowering of blood glucose is required and metformin alone does not achieve targets. In people who cannot tolerate sulfonylureas or who have a higher risk of hypoglycemia, doctors may prefer alternatives that do not directly stimulate insulin release.
Regular monitoring is essential. Your clinician will review your response to treatment and watch for signs of low blood sugar, weight changes, or other adverse effects. You should report any new symptoms, changes in weight, or a shift in energy levels promptly so adjustments can be made safely.
Glimepiride acts by closing potassium channels in pancreatic beta cells, which leads to cell membrane depolarisation and a rise in calcium inside the cell. The final effect is increased insulin release from the pancreas in response to meals or elevated blood glucose. This mechanism makes Amaryl a glucose-lowering agent that acts in part by stimulating the body's own insulin production.
Compared with non-sulfonylurea medicines, Amaryl and other sulfonylureas share the goal of lowering blood sugar through insulin release. However, the timing and magnitude of insulin release differ among agents, and this can affect how quickly blood sugar responds and how long the effect lasts. For example, some sulfonylureas are designed for longer or shorter action, which influences dosing plans and hypoglycemia risk.
When compared with metformin, which reduces liver glucose output and improves insulin sensitivity, glimepiride acts through a direct stimulation of insulin secretion. This distinction helps explain why each drug can be complementary in combination regimens or preferred in different patient profiles. Your clinician will weigh these differences alongside your medical history when designing treatment.
In practice, individual responses vary. Amaryl may require once-daily dosing in many regimens, whereas some alternatives offer different dosing schedules or tolerability profiles. If you notice persistent side effects or concerns about how your treatment feels, talk with your healthcare professional about possible adjustments or alternatives.
| Name | Primary use | Typical onset | Key advantage |
|---|---|---|---|
| glimepiride (Amaryl) | Type 2 diabetes; helps improve blood sugar when diet/exercise alone are not enough | Onset typically within 2–4 hours; duration may extend through the day depending on formulation | Often prescribed for once-daily dosing; well-established among clinicians |
| gliclazide | Type 2 diabetes; similar role in lowering blood sugar | Onset usually within 2–4 hours; sustained-release forms available | Some formulations may have a lower hypoglycemia risk in certain patients |
| glipizide | Type 2 diabetes; alternative sulfonylurea option | Onset can be faster for certain immediate-release formulations | Flexible dosing options and potential for rapid action when meals are variable |
Take Amaryl exactly as prescribed by your clinician. It is usually taken once daily with breakfast or the first main meal to help reduce the risk of low blood sugar during the night. Do not change the timing or amount without talking to your doctor or pharmacist.
Swallow the tablet whole with a drink of water. Do not chew or crush the tablet unless your healthcare professional has told you to. Some patients may use a sustained-release form; follow the specific instructions for that preparation if provided.
Keep a regular eating pattern and monitor your carbohydrate intake since skipping meals or fasting for long periods can increase the risk of hypoglycemia when taking Amaryl. If you need to miss a meal, discuss what to do with your clinician before continuing the usual dose.
If you have a significant change in activity, illness, or stress, your blood sugar can change. Your doctor may need to adjust your treatment. If you are taking other diabetes medicines, including insulin or other sulfonylureas, your risk of low blood sugar may be higher and requires closer monitoring.
Storage should be at room temperature, in a dry place away from light. Keep medicines out of reach of children. If you have unused medicine or it expires, do not use it; ask your pharmacist how to dispose of it safely.
The most common issue with Amaryl is low blood sugar (hypoglycemia). Signs can include sweating, trembling, fast heartbeat, dizziness, confusion, or hunger. Your risk may be higher if you skip meals, exercise more than usual, or drink alcohol while taking Amaryl. Seek urgent medical help if symptoms are severe or you cannot treat them with a snack or drink containing sugar.
Other potential side effects include weight gain, nausea, abdominal upset, or headache. Some people may experience dizziness or fatigue, which can affect daily activities. If adverse effects are persistent or bothersome, speak with your healthcare professional about whether continuing Amaryl is appropriate.
Who should not use Amaryl? People with type 1 diabetes or diabetic ketoacidosis should not take it. It is not suitable for everyone; individuals with severe liver or kidney disease, a history of severe hypoglycemia, or known allergy to sulfonylureas should be evaluated carefully. Pregnant or breastfeeding individuals should discuss treatment choices with their clinician, as alternatives may be preferred.
Less common but serious reactions can occur with any medicine. If you notice signs of an allergic reaction, skin rashes, swelling of the face or throat, or other unusual symptoms, seek medical attention. Your pharmacist or doctor can help assess whether Amaryl is appropriate for you given your health status.
Several medicines can interact with Amaryl and affect blood glucose. The risk of hypoglycemia can rise when Amaryl is used with other glucose-lowering therapies, including insulin. Always tell your clinician about all medicines you take, including over‑the‑counter drugs and supplements.
Alcohol can also influence blood sugar and may increase the risk of hypoglycemia when combined with Amaryl. Some medicines may alter how glimepiride is processed by the body, which could change its effect. If you start or stop any other prescription or non-prescription medicines, review this with your pharmacist or doctor.
Because interactions depend on your overall health and other medicines, you should check the official patient information leaflet for Amaryl and discuss any concerns with a healthcare professional. If you notice new symptoms after starting a new medicine, contact your clinician promptly.
Older adults may have a higher sensitivity to low blood sugar with sulfonylureas. Your clinician might start at a lower dose and monitor closely. People with kidney or liver impairment require careful assessment because they may respond differently to Amaryl and may have altered drug elimination.
Pregnancy and breastfeeding require careful decision-making. If you are planning pregnancy or are pregnant, or if you are breastfeeding, discuss all diabetes medications with your clinician to choose the safest option for you and the baby.
Regular monitoring of blood glucose, kidney and liver function, and body weight helps ensure safe use. If you notice symptoms such as confusion, rapid heartbeat, or fainting, seek medical help promptly. Do not adjust treatment on your own based on self‑assessment alone.
If you have previously experienced a severe allergic reaction to a sulfonylurea, avoid Amaryl unless advised otherwise by a clinician. Always follow the direction given on the official patient information and by your pharmacist.
There is no single “best” sulfonylurea for everyone. Amaryl may suit some patients because of how it fits with daily routines or its particular safety profile, while others may respond better to a different agent. A clinician weighs factors such as blood sugar patterns, risk of hypoglycemia, kidney function, and other medications when choosing among sulfonylureas.
Switching can be appropriate when a doctor sees a benefit from Amaryl’s action or tolerability. The doctor will guide the process, including any necessary adjustments during the transition, and how to monitor blood sugar during the change.
Generic glimepiride is available in many markets. The active ingredient remains the same, and effectiveness is expected to be similar when used as directed. Differences, if any, are usually related to manufacturing and excipients, not the therapeutic effect. If you have concerns, ask your pharmacist.
Metformin and glimepiride have different mechanisms. Metformin lowers sugar production by the liver and improves insulin sensitivity, while glimepiride stimulates insulin release. In many treatment plans, metformin is used first, with a sulfonylurea added later if needed. The choice depends on a person’s overall health and how their blood sugar responds.
Alcohol can affect blood sugar control and may increase the risk of hypoglycemia when taken with Amaryl. If you drink alcohol, discuss it with your clinician to understand how it may affect your regimen and blood glucose monitoring.
Missing a dose may increase blood sugar, depending on the timing and your meals. If you realize soon after a dose was skipped, contact your clinician or pharmacist for guidance. Do not double the next dose without advice, especially if your meals are irregular.
Using Amaryl with insulin can increase the risk of hypoglycemia. Your clinician may adjust your treatment plan, which could involve modifying insulin dosing or stopping Amaryl. Do not change therapy without professional guidance.
Your healthcare team can provide the official patient information leaflet that accompanies Amaryl. This page offers general education and is not a substitute for personalized advice. If you have questions about how Amaryl fits with your health goals, contact your doctor or pharmacist for tailored guidance.
For additional information, consider speaking with a pharmacist about how Amaryl interacts with any other medicines you take, including over‑the‑counter products and supplements. Always store medicines as directed and keep them out of reach of children. If you notice any unexpected symptoms after starting Amaryl, seek medical advice promptly.
In the United Kingdom, treatments and recommendations may vary by region and over time. Check the official patient information leaflet and local guidance to ensure you have the most current, safety-focused advice. When in doubt, consult your healthcare professional for clarification and support.
14–21 days. Free from £147.64 .
5–9 days. £22.15
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
